ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 117.25

Change

0.00 (0.00)%

Market Cap

USD 1.10B

Volume

0.16M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

-0.15 (-0.21%)

USD 6.66B
OPCH Option Care Health Inc

-0.03 (-0.10%)

USD 5.24B
AMED Amedisys Inc

-0.10 (-0.10%)

USD 3.12B
SGRY Surgery Partners Inc

-0.71 (-2.67%)

USD 3.11B
LFST Lifestance Health Group Inc

+0.31 (+4.52%)

USD 2.62B
AMEH Astrana Health Inc.

N/A

USD 1.86B
ADUS Addus HomeCare Corporation

+1.31 (+1.20%)

USD 1.79B
ASTH Astrana Health Inc

+0.26 (+0.67%)

USD 1.77B
HCSG Healthcare Services Group Inc

+0.17 (+1.53%)

USD 0.80B
PNTG Pennant Group Inc

+0.75 (+3.31%)

USD 0.65B

ETFs Containing ENSG

IJT iShares S&P Small-Cap 600.. 1.11 % 0.25 %

+0.04 (+0.89%)

USD 5.80B
SLYG SPDR® S&P 600 Small Cap .. 1.09 % 0.15 %

+0.09 (+0.89%)

USD 3.19B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 1.05 % 0.00 %

N/A

USD 0.12B
MWON:XETRA Amundi S&P SmallCap 600 E.. 1.05 % 0.00 %

+0.47 (+0.89%)

USD 0.12B
USASUS:SW Amundi S&P SmallCap 600 E.. 1.05 % 0.00 %

+0.56 (+0.89%)

USD 0.12B
ESIX SPDR S&P SmallCap 600 ESG.. 0.79 % 0.00 %

+0.03 (+0.89%)

USD 4.46M
SMLE DBX ETF Trust - S&P Small.. 0.75 % 0.00 %

+0.08 (+0.89%)

USD 1.35M
QVMS Invesco Exchange-Traded F.. 0.63 % 0.00 %

+0.03 (+0.89%)

USD 0.19B
IDP6:LSE iShares S&P Small Cap 600.. 0.59 % 0.00 %

+0.80 (+0.89%)

USD 1.71B
ZSML:CA BMO S&P US Small Cap Inde.. 0.59 % 0.00 %

+0.49 (+0.89%)

N/A
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.59 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.59 % 0.00 %

N/A

N/A
IDP6:SW iShares S&P SmallCap 600 .. 0.59 % 0.00 %

+0.78 (+0.89%)

USD 1.74B
IUS3:F iShares S&P Small Cap 600.. 0.59 % 0.00 %

+0.46 (+0.89%)

USD 1.75B
VIOO Vanguard S&P Small-Cap 60.. 0.58 % 0.15 %

+0.10 (+0.89%)

USD 2.48B
IJR iShares Core S&P Small-Ca.. 0.57 % 0.07 %

+0.33 (+0.89%)

USD 78.60B
ISP6:LSE iShares III Public Limite.. 0.56 % 0.00 %

+44.50 (+0.89%)

USD 1.76B
SAA ProShares Ultra SmallCap6.. 0.42 % 0.95 %

+0.15 (+0.89%)

USD 0.03B
DFAS Dimensional U.S. Small Ca.. 0.29 % 0.00 %

-0.02 (0.89%)

USD 8.04B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

+0.16 (+0.89%)

USD 0.20B
SPSM SPDR® Portfolio S&P 600 .. 0.00 % 0.06 %

+0.07 (+0.89%)

USD 10.09B
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

-0.12 (0.89%)

USD 0.34B
OLD 0.00 % 0.50 %

N/A

N/A
RNMC First Trust Mid Cap US Eq.. 0.00 % 0.60 %

+0.02 (+0.89%)

USD 0.02B
OSCV 0.00 % 0.79 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
SLY 0.00 % 0.15 %

N/A

N/A
VIOG Vanguard S&P Small-Cap 60.. 0.00 % 0.20 %

-0.05 (0.89%)

USD 0.80B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

+0.62 (+0.89%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.49% 73% C 70% C-
Dividend Return 0.05% 100% F 1% F
Total Return 4.55% 73% C 68% D+
Trailing 12 Months  
Capital Gain 20.76% 86% B+ 77% C+
Dividend Return 0.24% 100% F 2% F
Total Return 21.01% 86% B+ 76% C+
Trailing 5 Years  
Capital Gain 128.42% 91% A- 88% B+
Dividend Return 2.10% 50% F 9% A-
Total Return 130.52% 91% A- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 27.33% 75% C 84% B
Dividend Return 27.66% 75% C 84% B
Total Return 0.33% 50% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 41.35% 54% F 43% F
Risk Adjusted Return 66.90% 96% N/A 89% A-
Market Capitalization 1.10B 96% N/A 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 65% 30%
Price/Book Ratio 4.55 12% 25%
Price / Cash Flow Ratio 17.71 27% 15%
Price/Free Cash Flow Ratio 23.03 22% 10%
Management Effectiveness  
Return on Equity 15.28% 93% 85%
Return on Invested Capital 12.65% 90% 82%
Return on Assets 4.18% 76% 83%
Debt to Equity Ratio 9.75% 67% 71%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector